Market Overview

UPDATE: JP Morgan Raises PT on McKesson Corporation on Updated F2014 EPS Estimate

Share:
Related MCK
Generic Drug Price Deflation Is Weighing On McKesson Shares
Goldman Drops McKesson To Neutral, Sees Limited Upside
Please Fill My Rx For McKesson Corporation (Seeking Alpha)

In a report published Tuesday, JP Morgan reiterated its Overweight rating on McKesson Corporation (NYSE: MCK) and raised its price target from $111.00 to $112.00.

JP Morgan reported that, “We believe there could be upside to our estimates driven by a variety of factors better business performance, lower interest expense, greater share repurchases) yet we are comfortable with our estimates given that we view F2014 as a transition year for McKesson

McKesson Corporation closed at $102.12 on Monday.

Latest Ratings for MCK

DateFirmActionFromTo
Sep 2016Goldman SachsDowngradesBuyNeutral
Aug 2016JP MorganMaintainsOverweight
Jul 2016Morgan StanleyMaintainsOverweight

View More Analyst Ratings for MCK
View the Latest Analyst Ratings

Posted-In: JP MorganAnalyst Color Price Target Analyst Ratings

 

Related Articles (MCK)

View Comments and Join the Discussion!